Endometrial Carcinoma - Erler Zimmer

MP2106
238.MP2106
4 to 7 days
+
1.031,00 net*
Need help?
More ways of contacting us
CUSTOMER SUPPORT

Whether you're looking for answers, would like to solve a problem, or just want to let us know how we did, you'll find many ways to contact us right here. If you'd like to place an order or have questions regarding your stethoscope.eu order, you can contact us:

  • by using the chat app on bottom right corner of our web page, during business hours (9AM GMT+2 – 5PM GMT+2, 5 days a week) we respond immediately
  • by using our facebook page at https://www.facebook.com/Stethoscope.EU
  • by using the contact form below
  • by phone at +302310005015


If we are offline, we will get back to you as soon as possible. We will do our best to serve you as fast as possible.
Business Hours
Monday: 9:00 AM – 5:00 PM
Tuesday: 9:00 AM – 5:00 PM
Wednesday: 9:00 AM – 5:00 PM
Thursday: 9:00 AM – 5:00 PM
Friday: 9:00 AM – 5:00 PM
Saturday: Closed
Sunday: Closed
Give Feedback

Endometrial Carcinoma - Erler Zimmer

Clinical History

A 63-year-old woman presented with a history of dull lower abdominal pain for 2 months and heavy persistent vaginal bleeding for 1 week. The menopause had occurred 13 years previously. Radical abdominal hysterectomy and bilateral salpingo-oophorectomy were commonly performed for the treatment of endometrial cancer following confirmation of endometrial carcinoma in biopsy.

Pathology

The specimen consists of the uterus, fallopian tubes, and ovaries. The endometrial cavity and endocervical canal have been opened on the anterior aspect. The endometrial lining is grossly abnormal especially on the right side and a brown polypoid tumor has invaded the myometrium and extends inferiorly into the cervical canal. Histologically this was a well-differentiated adenocarcinoma of the endometrium. The left ovary, which has been sectioned in the coronal plane, is enlarged and has several large follicular cysts/cavities.

Further Information

Endometrial carcinoma is the most common gynecological malignancy in developed countries and the second most common in developing countries after cervical cancer. There are two major types of endometrial carcinoma. Endometrioid carcinoma accounts for almost 80% of endometrial carcinoma. They usually present early and so have a more favorable outcome. These tumors may arise from atypical endometrial hyperplasia. Common genetic abnormalities seen in endometrioid tumors are mutations in the PTEN, PIK3Ca, and ARID1A genes. Serous carcinoma is a less common form of endometrial carcinoma. These tumors are associated with mutations in TP53 gene and carry a poorer prognosis. Endometrioid tumors tend to affect women aged 55 to 65 years. Risk factors for developing endometrioid endometrial cancer include obesity, impaired glucose tolerance, infertility, unopposed estrogen therapy (e.g. early menarche, late menopause, or exogenous sources). Serous neoplasms affect older women aged 65 to 75 years with other risk factors for development include having a lower BMI and an atrophic uterus. Women with Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) have a significantly higher risk of developing endometrial cancer.

The most common symptom of endometrial cancer is abnormal vaginal bleeding. Most frequently it presents as post-menopausal bleeding, which often allows early presentation. Others may be asymptomatic or an incidental finding of an abnormal endometrium on abdominopelvic imaging. The main radiological sign of endometrial cancer is abnormally thickened endometrium on pelvic ultrasound or CT scan. Diagnosis is made on endometrial biopsy, endometrial curettage, or hysterectomy. Treatment depends on the stage of the cancer and includes local radiotherapy, systemic chemotherapy, and surgical hysterectomy +/- salpingo-oophorectomy.

Brand:
Erler Zimmer
Age group:
adult

No posts found

Write a review
Assistant
Need help?